PMD Device Solutions AB (OSTO:PMDS) Total Operating Expense: kr46.41 Mil (TTM As of Sep. 2024)


OSTO:PMDS PMD Device Solutions AB OSTO:PMDS
4 GF Score
Price kr0.66
View Full Analysis

What is PMD Device Solutions AB Total Operating Expense?

PMD Device Solutions AB OSTO:PMDS 4 Total Operating Expense is kr46.41 Mil as of Sep. 2024. GuruFocus rates OSTO:PMDS with a GF Score™ of 4/100.

PMD Device Solutions AB's Total Operating Expense for the three months ended in Sep. 2024 was kr16.17 Mil. PMD Device Solutions AB's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was kr46.41 Mil.


PMD Device Solutions AB Total Operating Expense Related Terms


PMD Device Solutions AB Total Operating Expense Historical Data

* Premium members only.

The historical data trend for PMD Device Solutions AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PMD Device Solutions AB Total Operating Expense Chart

PMD Device Solutions AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial 12.70 10.90 11.80 10.76 0.00

PMD Device Solutions AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.31 0.00 11.51 18.74 16.17
OSTO:PMDS
4GF Score
PMD Device Solutions AB OSTO:PMDS
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PMD Device Solutions AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr46.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of kr46.41 Mil mean?
PMD Device Solutions AB (OSTO:PMDS) has a Total Operating Expense of kr46.41 Mil as of Sep. 2024. Total operating expense is the primary recurring expense associated with central operations. View historical data on PMD Device Solutions AB and its competitors.
Is PMD Device Solutions AB's Total Operating Expense too high?
PMD Device Solutions AB's current Total Operating Expense is kr46.41 Mil. Overall, PMD Device Solutions AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does PMD Device Solutions AB's Total Operating Expense compare to ABT and SYK?
PMD Device Solutions AB's Total Operating Expense of kr46.41 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on PMD Device Solutions AB and its competitors. PMD Device Solutions AB's current Total Operating Expense is kr46.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMD Device Solutions AB stock overvalued right now?
PMD Device Solutions AB (OSTO:PMDS) has a current Total Operating Expense of kr46.41 Mil. The current Total Operating Expense is kr46.41 Mil. PMD Device Solutions AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For PMD Device Solutions AB (OSTO:PMDS), the current Total Operating Expense is kr46.41 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PMD Device Solutions AB Business Description

Address C/o Eversheds Sutherland Advokatbyra AB, Box 14055, Stockholm, SWE, 104 40
PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.
4GF Score

Get the complete analysis for OSTO:PMDS

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.66
Price